Loading...

Sino Biopharmaceutical Limited

SBHMY•PNK
Healthcare
Biotechnology
$19.50
$0.00(0.00%)

Sino Biopharmaceutical Limited (SBHMY) Stock Overview

Explore Sino Biopharmaceutical Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap17.4B
P/E Ratio34.35
EPS (TTM)$0.60
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Week$9.48
1 Month$9.20
3 Months$8.97
1 Year Target$7.89

SBHMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sino Biopharmaceutical Limited (SBHMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 99.10, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $7.89.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 34.35 and a market capitalization of 17.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.40%
5-Day Change
-9.85%
1-Month Change
9.06%
3-Month Change
15.81%
6-Month Change
9.88%
Year-to-Date (YTD) Change
5.40%
1-Year Change
22.08%
3-Year Change
-16.52%
5-Year Change
-47.27%
All-Time (Max) Change
3.53%

Contact Information

https://www.sinobiopharm.com
852 2802 9886
Office Tower, Wan Chai

Company Facts

24,379 Employees
IPO DateSep 5, 2017
CountryHK
Actively Trading

Frequently Asked Questions

;